We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.80 | -0.43% | 183.60 | 182.60 | 183.20 | 184.00 | 182.00 | 183.00 | 218,849 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 24.95 | 396.63M |
TIDMAMS
RNS Number : 0347Y
Advanced Medical Solutions Grp PLC
30 November 2017
30 November 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces it was notified on 27 November 2017 that Chris Meredith, who is a Director and PDMR, following the end of the holding period, has exercised 22,203 options from the Deferred Annual Bonus Plan (DAB). Mr Meredith elected to receive an additional 296 dividend shares which were earned during the 3 year holding period under the terms of this scheme. Mr Meredith subsequently sold 10,726 Ordinary Shares of 5p each on 27 November 2017 at a share price of 312.109p per Ordinary Share to cover the tax and National Insurance payable on this exercise.
As a result of these transactions Chris Meredith's beneficial interest in the Company has increased from 1,470,306 shares to 1,482,079 shares.
Deferred Annual Bonus Plan (DAB)
Director DABs DABs Dividend Ordinary Ordinary DABs prior exercised Shares Shares Shares after to exercise received sold retained exercise ----------------- ------------- ----------- ---------- --------- ---------- ---------- Chris Meredith, Chief Executive Officer 105,587 22,203 296 10,726 11,773 83,384 ----------------- ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
Director Holding Number Dividend Number Sale Resultant % of prior of shares Shares of shares price holding issued to exercise exercised received sold (p) share capital ----------------- ------------- ----------- ---------- ----------- --------- ---------- --------- Chris Meredith, Chief Executive Officer 1,470,306 22,203 296 10,726 312.109p 1,482,079 0.7% ----------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27 November 2017 that Mary Tavener, who is a Director and PDMR, following the end of the holding period, has exercised 17,207 options from the Deferred Annual Bonus Plan (DAB). Mrs Tavener elected to receive an additional 229 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mrs Tavener subsequently sold 8,313 Ordinary Shares of 5p each on 27 November 2017 at a share price of 312.109p per Ordinary Share to cover the tax and National Insurance payable on this exercise.
As a result of these transactions Mary Tavener's beneficial interest in the Company has increased from 1,950,568 shares to 1,959,691 shares.
Deferred Annual Bonus Plan (DAB)
Director DABs DABs Dividend Ordinary Ordinary DABs prior exercised Shares Shares Shares after to exercise received sold retained exercise ------------------ ------------- ----------- ---------- --------- ---------- ---------- Mary Tavener, Chief Financial Officer 72,935 17,207 229 8,313 9,123 55,728 ------------------ ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
Director Holding Number Dividend Number Sale Resultant % of prior of shares Shares of shares price holding issued to exercise exercised received sold (p) share capital --------------- ------------- ----------- ---------- ----------- --------- ---------- --------- Mary Tavener, Chief Financial Officer 1,950,568 17,207 229 8,313 312.109p 1,959,691 0.92% --------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27 November 2017 that Eddie Johnson, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 38,450 options from the Long Term Incentive Plan (LTIP). Mr Johnson has also, following the end of the holding period, exercised 3,115 options from the Deferred Annual Bonus Plan (DAB). Mr Johnson elected to receive an additional 41 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr Johnson subsequently sold 41,606 Ordinary Shares of 5p each on 27 November 2017 at a share price of 312.109p per Ordinary Share. Following these transactions the beneficial ownership of Eddie Johnson is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs Ordinary Ordinary LTIPs LTIPs prior exercised lapsed Shares Shares after to exercise sold retained exercise --------------- ------------- ----------- -------- --------- ---------- ---------- Eddie Johnson 144,139 38,450 11,550 38,450 Nil 94,139 --------------- ------------- ----------- -------- --------- ---------- ----------
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs prior exercised Shares Shares Shares after to exercise received sold retained exercise --------------- ------------- ----------- ---------- --------- ---------- ---------- Eddie Johnson 19,359 3,115 41 3,156 Nil 16,244 --------------- ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of prior of shares Shares of shares price holding issued to exercise exercised received sold (p) share capital --------------- ------------- ----------- ---------- ----------- --------- ---------- --------- Eddie Johnson 48,734 41,565 41 41,606 312.109p 48,734 0.023% --------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27 November 2017 that Pieter van Hoof, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 38,450 options from the Long Term Incentive Plan (LTIP). Mr van Hoof has also, following the end of the holding period, exercised 2,993 options from the Deferred Annual Bonus Plan (DAB). Mr van Hoof elected to receive an additional 39 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr van Hoof has also elected to exercise 38,387 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB).
Mr van Hoof subsequently sold 32,810 Ordinary Shares of 5p each on 27 November 2017 at a share price of 312.109p per Ordinary Share to cover the tax and National Insurance payable on this exercise. As a result of these transactions Pieter van Hoof's beneficial interest in the Company has increased from 76,282 shares to 123,341 shares.
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs Ordinary Ordinary LTIPs LTIPs prior exercised lapsed Shares Shares after to exercise sold retained exercise ------------ ------------- ----------- -------- --------- ---------- ---------- Pieter van Hoof 144,933 38,450 11,550 15,802 22,648 94,933 ------------ ------------- ----------- -------- --------- ---------- ----------
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs prior exercised Shares Shares Shares after to exercise received sold retained exercise ------------ ------------- ----------- ---------- --------- ---------- ---------- Pieter van Hoof 17,819 2,993 39 1,230 1,802 14,826 ------------ ------------- ----------- ---------- --------- ---------- ----------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after prior to Shares Shares exercise exercise sold retained ------------ ------------ --------------- --------- ---------- ----------- Pieter van Hoof 60,057 38,387 15,778 22,609 21,670 ------------ ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of prior of shares Shares of shares price holding issued to exercise exercised received sold (p) share capital ------------ ------------- ----------- ---------- ----------- --------- ---------- --------- Pieter van Hoof 76,282 79,830 39 32,810 312.109p 123,341 0.058% ------------ ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27 November 2017 that Jeff Willis, who is a Senior Manager and PDMR, following the end of the holding period, has exercised 2,437 options from the Deferred Annual Bonus Plan (DAB). Mr Willis elected to receive an additional 32 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr Willis has also elected to exercise 5,617 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Willis subsequently sold 12,512 Ordinary Shares of 5p each on 27 November 2017 at a share price of 312.109p per Ordinary Share. As a result of these transactions Jeff Willis's beneficial interest in the Company has decreased from 165,765 shares to 161,339 shares.
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs prior exercised Shares Shares Shares after to exercise received sold retained exercise ------------- ------------- ----------- ---------- --------- ---------- ---------- Jeff Willis 23,531 2,437 32 2,469 Nil 21,094 ------------- ------------- ----------- ---------- --------- ---------- ----------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after prior to Shares Shares exercise exercise sold retained ------------- ------------ --------------- --------- ---------- ----------- Jeff Willis 31,426 5,617 5,617 Nil 25,809 ------------- ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of prior of shares Shares of shares price holding issued to exercise exercised received sold (p) share capital ------------- ------------- ----------- ---------- ----------- --------- ---------- --------- Jeff Willis 165,765 8,054 32 12,512 312.109p 161,339 0.075% ------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person closely associated --- ---------------------------------------------------------------- a) Name: Chris Meredith --- ---------------------------------------------------------------- 2. Reason for the notification --- ---------------------------------------------------------------- a) Position/status: Director/PDMR --- ---------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- ---------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- ---------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- ---------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- ---------------------------------------------------------------- b) Nature of the transactions: * Exercise of 22,203 shares from the Deferred Annual Bonus Plan * Award of 296 Dividend Shares from the Deferred Annual Bonus Plan * Sale of 10,726 Ordinary Shares of 5p --- ---------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------ ---------- GBP3.12109 10,726 ------------ ---------- --- ---------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 10,726 Aggregated price: GBP3.12109 --- ---------------------------------------------------------------- e) Date of the transaction: 27/11/2017 --- ---------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ---------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- ---------------------------------------------------------------- a) Name: Mary Tavener --- ---------------------------------------------------------------- 2. Reason for the notification --- ---------------------------------------------------------------- a) Position/status: Director/PDMR --- ---------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- ---------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- ---------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- ---------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- ---------------------------------------------------------------- b) Nature of the transactions: * Exercise of 17,207 shares from the Deferred Annual Bonus Plan * Award of 229 Dividend Shares from the Deferred Annual Bonus Plan * Sale of 8,313 Ordinary Shares of 5p --- ---------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------ ---------- GBP3.12109 8,313 ------------ ---------- --- ---------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 8,313 Aggregated price: GBP3.12109 --- ---------------------------------------------------------------- e) Date of the transaction: 27/11/2017 --- ---------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ---------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Eddie Johnson --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transaction: * Exercise of 38,450 shares from the Long Term Incentive Plan * Exercise of 3,115 shares from the Deferred Annual Bonus Plan * Award of 41 Dividend Shares from the Deferred Annual Bonus Plan * Sale of 41,606 Ordinary Shares of 5p --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------ ---------- GBP3.12109 41,606 ------------ ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 41,606 Aggregated price: GBP3.12109 --- --------------------------------------------------------------- e) Date of the transaction: 27/11/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Pieter van Hoof --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Exercise of 38,450 shares from the Long Term Incentive Plan * Exercise of 2,993 shares from the Deferred Annual Bonus Plan * Award of 39 Dividend Shares from the Deferred Annual Bonus Plan * Exercise of 38,387 shares from the Deferred Share Bonus Plan * Sale of 32,810 Ordinary Shares of 5p --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------ ---------- GBP3.12109 32,810 ------------ ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 32,810 Aggregated price: GBP3.12109 --- --------------------------------------------------------------- e) Date of the transaction: 27/11/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------- a) Name: Jeff Willis --- --------------------------------------------------------------- 2. Reason for the notification --- --------------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- --------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- --------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- --------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- --------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- --------------------------------------------------------------- b) Nature of the transactions: * Exercise of 2,437 shares from the Deferred Annual Bonus Plan * Award of 32 Dividend Shares from the Deferred Annual Bonus Plan * Exercise of 5,617 shares from the Deferred Share Bonus Plan * Sale of 12,512 Ordinary Shares of 5p --- --------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------ ---------- GBP3.12109 12,512 ------------ ---------- --- --------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 12,512 Aggregated price: GBP3.12109 --- --------------------------------------------------------------- e) Date of the transaction: 27/11/2017 --- --------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ---------------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0) plc 1606 545508 Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com / Philippa Gardner / Rosie Phillips Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970 Daniel Adams / Gary Clarence / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUBDBDUXBGRG
(END) Dow Jones Newswires
November 30, 2017 10:54 ET (15:54 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions